SK channel blockade prevents hypoxia-induced ventricular arrhythmias through inhibition of Ca2+/voltage uncoupling in hypertrophied hearts

Am J Physiol Heart Circ Physiol. 2021 Apr 1;320(4):H1456-H1469. doi: 10.1152/ajpheart.00777.2020. Epub 2021 Feb 26.

Abstract

Ventricular arrhythmia (VA) is the major cause of death in patients with left ventricular (LV) hypertrophy and/or acute ischemia. We hypothesized that apamin, a blocker of small-conductance Ca2+-activated K+ (SK) channels, alters Ca2+ handling and exhibits anti-arrhythmic effects in ventricular myocardium. Spontaneous hypertensive rats were used as a model of LV hypertrophy. A dual optical mapping of membrane potential (Vm) and intracellular calcium (Cai) was performed during global hypoxia (GH) on the Langendorff perfusion system. The majority of pacing-induced VAs during GH were initiated by triggered activities. Pretreatment of apamin (100 nmol/L) significantly inhibited the VA inducibility. Compared with SK channel blockers (apamin and NS8593), non-SK channel blockers (glibenclamide and 4-AP) did not exhibit anti-arrhythmic effects. Apamin prevented not only action potential duration (APD80) shortening (-18.7 [95% confidence interval, -35.2 to -6.05] ms vs. -2.75 [95% CI, -10.45 to 12.65] ms, P = 0.04) but also calcium transient duration (CaTD80) prolongation (14.52 [95% CI, 8.8-20.35] ms vs. 3.85 [95% CI, -3.3 to 12.1] ms, P < 0.01), thereby reducing CaTD80 - APD80, which denotes "Cai/Vm uncoupling" (33.22 [95% CI, 22-48.4] ms vs. 6.6 [95% CI, 0-14.85] ms, P < 0.01). The reduction of Cai/Vm uncoupling was attributable to less prolonged Ca2+ decay constant and suppression of diastolic Cai increase by apamin. The inhibition of VA inducibility and changes in APs/CaTs parameters caused by apamin was negated by the addition of ouabain, an inhibitor of Na+/K+ pump. Apamin attenuates APD shortening, Ca2+ handling abnormalities, and Cai/Vm uncoupling, leading to inhibition of VA occurrence in hypoxic hypertrophied hearts.NEW & NOTEWORTHY We demonstrated that hypoxia-induced ventricular arrhythmias were mainly initiated by Ca2+-loaded triggered activities in hypertrophied hearts. The blockades of small-conductance Ca2+-activated K+ channels, especially "apamin," showed anti-arrhythmic effects by alleviation of not only action potential duration shortening but also Ca2+ handling abnormalities, most notably the "Ca2+/voltage uncoupling."

Keywords: calcium signaling; cardiac hypertrophy; ion channel; ischemia; small-conductance Ca2+-activated K+ channels (SK channels); ventricular arrhythmia.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Naphthylamine / analogs & derivatives
  • 1-Naphthylamine / pharmacology
  • Action Potentials / drug effects
  • Animals
  • Anti-Arrhythmia Agents / pharmacology*
  • Apamin / pharmacology
  • Arrhythmias, Cardiac / etiology
  • Arrhythmias, Cardiac / metabolism
  • Arrhythmias, Cardiac / physiopathology
  • Arrhythmias, Cardiac / prevention & control*
  • Calcium Signaling / drug effects*
  • Cardiac Pacing, Artificial
  • Cardiomegaly / complications
  • Cardiomegaly / drug therapy*
  • Cardiomegaly / metabolism
  • Cardiomegaly / physiopathology
  • Disease Models, Animal
  • Heart Rate / drug effects*
  • Hypoxia / complications
  • Hypoxia / drug therapy*
  • Hypoxia / metabolism
  • Hypoxia / physiopathology
  • Isolated Heart Preparation
  • Male
  • Potassium Channel Blockers / pharmacology*
  • Rats
  • Rats, Inbred SHR
  • Small-Conductance Calcium-Activated Potassium Channels / antagonists & inhibitors*
  • Small-Conductance Calcium-Activated Potassium Channels / metabolism
  • Time Factors

Substances

  • (R)-N-(benzimidazol-2-yl)-1,2,3,4-tetrahydro-1-naphthylamine
  • Anti-Arrhythmia Agents
  • Potassium Channel Blockers
  • Small-Conductance Calcium-Activated Potassium Channels
  • Apamin
  • 1-Naphthylamine